FOSTER CITY, Calif., April 14, 2026 (GLOBE NEWSWIRE) — Geron Company (Nasdaq: GERN), a business stage biopharmaceutical firm, right now reported that it granted an fairness award within the type of a inventory choice to buy 2,500,000 shares of Geron frequent inventory to Timothy Williams, Geron’s new Government Vice President, Chief Authorized Officer and Company Secretary, as an inducement materials to his acceptance of employment with Geron.
The inventory choice was granted on April 13, 2026. The inventory choice has an train value of $1.73 per share, which is the same as the closing value of Geron’s frequent inventory on the grant date, has a ten-year time period and vests over 4 years, with 12.5% of the shares underlying the choice vesting on the six-month anniversary of graduation of his employment and the remaining shares vesting over the next 42 months in equal installments of entire shares, topic to continued service with Geron via the relevant vesting dates.
The inventory choice grant was permitted by the Compensation Committee of Geron’s Board of Administrators in accordance with Nasdaq Itemizing Rule 5635(c)(4) and is topic to the phrases and circumstances of Geron’s 2018 Inducement Award Plan and the type of inventory choice settlement underneath that plan.
About Geron Geron is a commercial-stage biopharmaceutical firm aiming to vary lives by altering the course of blood most cancers. Our first-in-class telomerase inhibitor RYTELO® (imetelstat) is permitted in the US and the European Union for the therapy of sure grownup sufferers with lower-risk myelodysplastic syndromes with transfusion dependent anemia. We’re additionally conducting a pivotal Section 3 medical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis, in addition to research in different hematologic malignancies. Inhibiting telomerase exercise, which is elevated in malignant stem and progenitor cells within the bone marrow, goals to doubtlessly cut back proliferation and induce loss of life of malignant cells. To study extra, go to www.geron.com or observe us on LinkedIn.
